23948sdkhjf
Log in or create to bookmark articles
Get access to all content on Life Science Nordic
No commitment or card information required
Applies to personal subscription only.
Contact us for a enterprise solution.
Advertisement
Advertisement

Abbott expands by acquisition

An acquisition gives Abbott a leadership position in another large and growing medical device segment.
Advertisement
Abbott and Advanced

Medical Optics, AMO, have announced a definitive agreement for Abbott to acquire AMO for USD 22 per share in cash. The total transaction value is approximately USD 2,8 billion, inclusive of estimated net debt at the time of closing.

Advertisement
Based in Santa

Ana, in California, AMO is a global leader in ophthalmic care, comprised of three segments: cataract surgery, laser vision correction, Lasik, and eye care products. Globally, AMO holds the number one position in Lasik surgical devices, the number two position in the cataract surgical device market and the number three position in contact lens care products.

Advertisement
Population growth

and demographic shifts are increasing demand for advanced vision care technologies across all geographies and age groups. For example, about 60 percent of people older than 60 have cataracts, which are the leading cause of vision loss among this age group. It is estimated that 700 million people globally are 60 years or older, and that number is expected to grow to one billion over the next decade.

Advertisement
Advertisement
Advertisement
Life Science Sweden See topic
Advertisement Advertisement
BREAKING
{{ article.headline }}
0.031|instance-web02